DAVID JORDEN - 28 Nov 2025 Form 4 Insider Report for Nuo Therapeutics, Inc. (AURX)

Role: CEO/CFO, Director
Signature: /s/ David Jorden
Issuer symbol: AURX
Transactions as of: 28 Nov 2025
Transactions value $: -$300,000
Form type: 4
Filing time: 03 Dec 2025, 18:13:16 UTC
Previous filing: 04 Aug 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
JORDEN DAVID EMERSON	CEO/CFO, Director	C/O NUO THERAPEUTICS, INC., 8285 EL RIO, SUITE190, HOUSTON	/s/ David Jorden	03 Dec 2025	0001313516

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AURX	Common Stock	Sale	-$300K	-200K	-9.32%	$1.50	1.95M	28 Nov 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transaction reported herein was made in a private transaction to facilitate a personal real estate transaction whereby the shares of common stock acquired constitute "restricted" securities within the meaning of the Securities Act of 1933, as amended.